Format

Send to

Choose Destination
Ann Cardiol Angeiol (Paris). 2018 Apr;67(2):98-100. doi: 10.1016/j.ancard.2018.01.002. Epub 2018 Mar 27.

[Resistance to vitamin K antagonist revealing interaction with soy lecithin].

[Article in French]

Author information

1
Laboratoire de pharmacologie, faculté de medicine, avenue Magida-Boulila, 3029 Sfax, Tunisie. Electronic address: kamilia_ksouda@yahoo.fr.
2
Laboratoire de pharmacologie, faculté de medicine, avenue Magida-Boulila, 3029 Sfax, Tunisie.
3
Laboratoire de biochimie, hôpital Hédi Chaker, Sfax, Tunisie.
4
Service de gastro-entérologie, hôpital Hédi Chaker, Sfax, Tunisie.
5
Laboratoire de parasitologie, hôpital Habib Bourguiba, Sfax, Tunisie.

Abstract

Vitamin K antagonists (VKA) are difficult to use because of a narrow therapeutic index and of a marked inter- and intra-individual variability among patients in the required dosage. This drug may interact with many other drugs and same with certain food compounds. We report the case of potential interaction between soy lecithin and Vitamin K antagonists in a 46 years-old woman. Subtherapeutic INR values were detected despite the increase gradually in dose and replacing acenocoumarol by fluindione. An enquiry of pharmacovigilance was conducted found the consumption of soy lecithin capsules. Fifteen days after its stopping, the INR values have really increased. Clinicians should think to the possibility of interaction between oral anticoagulants and food supplement that is increasingly used.

KEYWORDS:

Antivitamine K; INR; Interaction; Lécithine de soja; Resistance; Résistance; Soy lecithin; Vitamin K antagonist

PMID:
29602443
DOI:
10.1016/j.ancard.2018.01.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center